| Date | Form | Description | Docs | XBRL | Pages |
| 10/28/21 | 8-K | Current report filing |
|
|
2 |
| 10/04/21 | 8-K | Current report filing |
|
|
2 |
| 09/03/21 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
2 | |
| 09/01/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
20 |
| 07/28/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/27/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/27/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/19/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Read More...